Botulax 150U
Clostridium botulinum toxin type A
Invest in quality and medical-grade botulinum toxin solution with Botulax 150 units! This highly purified neuromuscular solution is designed to relax dynamic wrinkles such as frown lines, forehead lines, and crow’s feet.
Botulax is available in 1 vial of 150U per package.
- Packaging 1 × 150U vial
- Injection depth Intramuscular or intradermal
- Duration 3–4 months
- Storage 2–8 °C
Description
Botulax 150U is a botulinum toxin type A product manufactured by Hugel, Inc., South Korea. It contains 150 units of Clostridium botulinum toxin type A and is supplied as a lyophilized formulation intended for professional preparation and administration. Botulax works by temporarily reducing targeted muscle activity at the neuromuscular junction. By limiting the release of acetylcholine involved in muscle contraction, botulinum toxin type A can temporarily reduce activity in targeted muscles.
Botulax 150U is part of the broader Botulax product range, which includes different unit strengths intended to provide healthcare professionals with presentation options for professional medical use. Introduced in 2009, this innovative Hugel product has taken the lead in South Korea’s cosmetic injectable business, establishing itself as a baseline for competitors. Clinical trials and years of research and development have shown its exceptional purity and long-lasting efficacy. It is designed to temporarily diminish moderate to severe frown lines, sometimes called glabellar wrinkles. It also helps with blepharospasm, which is involuntary blinking or twitching of the eyelids.
Botulax has three distinct advantages over other Botox medicines on the market: potency, price, and services. It is available in a variety of forms, including one containing 150 units of Clostridium botulinum Type A toxin. Botulax’s potency is continuously monitored in accordance with KFDA norms and the company’s stringent quality control standards. Furthermore, the pricing is reasonable for the quality. Furthermore, because medical specialists participated in Botulax’s product development, the company provides personalized therapy to its consumers, creating formulations matched to each individual’s needs.
Features of Botulax 150U
- Comes in a highly convenient dosage strength, perfect for superficial to severe wrinkle improvement
- Designed with a highly pure and stable complexing structure of botulinum toxin.
- Proven to be both effective and safe when injected.
- To alleviate benign essential blepharospasm
- Reduce the appearance of moderate to severe glabellar lines.
- Treat muscular spasms in the upper limbs
- Treatment of dynamic equinus foot deformity in pediatric cerebral palsy patients aged 2 and up.
- To enhance moderate to severe lateral canthal lines (crow’s feet lines)
- It has rapid effects, with results noticeable as early as three days after injection.
- Offers competitive pricing and good quality.
- It maintains a consistent potency and can be stored for 24 hours after reconstitution.
- Once injected into the target area, it does not easily diffuse to the surrounding areas, resulting in a substantially longer duration of action for a skeletal muscle relaxant solution.
Application sites
- Glabellar lines
- Crow’s feet
- Forehead lines
- Nose lines (Bunny lines/Vertical lines)
- Perioral lines
- Chin dimpling
- Jaw slimming
Duration of effect
Generally, the initial effect occurs within 2–4 days after the treatment session, and full results are evidently seen 1–2 weeks post-treatment. Every Botulax 150-unit treatment lasts for 3–4 months.
- Initial effect
- 2–4 days
- Full results
- 1–2 weeks
- Duration of effect
- 3–4 months
Product formulation
Botulax contains the following list of materials:
- 150 units of Clostridium botulinum Toxin Type A (Strain: CBFC26)
- 0.5 mg human serum albumin as a stabilizer
- 0.9 mg sodium chloride as the tonic adjuster
Specifications
| Packaging | 1 × 150U vial |
| Product appearance | Lyophilized white powder for injection in a colorless, transparent vial. It becomes a colorless, transparent liquid when mixed with a diluent (normal saline). |
| Composition | 150U Clostridium botulinum Toxin Type A, 0.5 mg Stabilizer (Human serum albumin), 0.9 mg tonic adjuster (Sodium chloride) |
| Injection depth | Intramuscular or intradermal |
| Cannula size | 27G–30G |
| Reconstitution | Must only be reconstituted with sterile saline solution |
| Treatment areas | Eyelids, glabella/frown lines, calf muscles, forehead, and hands |
| Treatment interval | Limit maintenance treatment sessions to 3 months after the initial procedure. This helps prevent tolerance and overdosage. |
| Duration of effect | 3–4 months |
| Storage | Store at 2–8 °C or refrigerate in its sealed container. |
| Shelf life | 36 months from manufacturing date |
| Manufacturer | Hugel Inc. |
Other Botulax strengths
Compare all five presentations side by side
Botulax 50U
A lower-unit presentation intended for professional use where the applicable product labeling calls for this strength, such as finer facial wrinkles and other superficial conditions.
Botulax 100U
A commonly supplied presentation containing 100 units of botulinum toxin type A per vial.
Botulax 200U
A higher-unit presentation intended for professional medical applications, as directed by the applicable labeling, especially in severe cases.
Botulax 300U
A high-volume formulation for high-dose treatments and larger surface areas, making it convenient and economical for both the clinic and patient.
Questions about Botulax 150U?
For questions about product availability, specifications, documentation, or professional purchasing, please contact our team.